Besides its role in HCC, it seems that testosterone may counteract oxidative damage-induced apoptosis in skeletal muscles by inactivating the p53 pathway [35] and that, in prostate cancer, p53 and AR reciprocally inhibit their functions (Figure 4a) [36,37]. The gene discussed is TP53; the disease is prostate carcinoma.